Global Covid-19 Diagnostic Market Research Report 2022

Report Format: PDF   |   Report ID: 5514361   |   Published Date: August 2022   |   Pages:  116  

Choose License
Market Analysis and Insights: Global Covid-19 Diagnostic Market
The global Covid-19 Diagnostic market size is projected to reach US$  million by 2028, from US$  million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Immunoassay accounting for % of the Covid-19 Diagnostic global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Covid-19 Diagnostic market size is valued at US$  million in 2021, while the North America and Europe Covid-19 Diagnostic are US$  million and US$  million, severally. The proportion of the North America is  % in 2021, while China and Europe are  % and respectively, and it is predicted that China proportion will reach  % in 2028, trailing a CAGR of  % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR  %,  %, and   % respectively for the next 6-year period. As for the Europe Covid-19 Diagnostic landscape, Germany is projected to reach US$  million by 2028 trailing a CAGR of  % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Covid-19 Diagnostic market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Covid-19 Diagnostic market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Covid-19 Diagnostic market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Covid-19 Diagnostic market.
Global Covid-19 Diagnostic Scope and Market Size
Covid-19 Diagnostic market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Covid-19 Diagnostic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
    Immunoassay
    Genomic and WGS Role
    rRT-PCR
Segment by Application
    Hospital
    Laboratory
By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    Asia-Pacific
        China
        Japan
        South Korea
        Southeast Asia
        India
        Australia
        Rest of Asia
    Latin America
        Mexico
        Brazil
        Rest of Latin America
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE
        Rest of MEA
By Company
    Abbott Diagnostics
    Accelerate Diagnostics
    Ador Diagnostics
    Akkoni Biosystems
    Alveo Technologies
    Applied BioCode
    Aus Diagnostics
    BD Diagnostics
    Biocartis
    BioFire Diagnostics
    bioM?(C)rieux
    Bio-Rad Laboratories
    Bosch Healthcare Solutions GmbH
    Cepheid
    Co-Diagnostics
    Cue Health
    Curetis
    Diagenode Diagnostics
    Diascopic
    Diasorin
    Expedeon
    Fusion Genomics.
    GenePOC Diagnostics
    GenMark Dx
    Hologic
    Immunexpress
    Inflammatix
    Invetech
    Janssen Diagnostics
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Covid-19 Diagnostic Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Immunoassay
        1.2.3 Genomic and WGS Role
        1.2.4 rRT-PCR
    1.3 Market by Application
        1.3.1 Global Covid-19 Diagnostic Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Laboratory
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Covid-19 Diagnostic Market Perspective (2017-2028)
    2.2 Covid-19 Diagnostic Growth Trends by Region
        2.2.1 Covid-19 Diagnostic Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Covid-19 Diagnostic Historic Market Size by Region (2017-2022)
        2.2.3 Covid-19 Diagnostic Forecasted Market Size by Region (2023-2028)
    2.3 Covid-19 Diagnostic Market Dynamics
        2.3.1 Covid-19 Diagnostic Industry Trends
        2.3.2 Covid-19 Diagnostic Market Drivers
        2.3.3 Covid-19 Diagnostic Market Challenges
        2.3.4 Covid-19 Diagnostic Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Covid-19 Diagnostic Players by Revenue
        3.1.1 Global Top Covid-19 Diagnostic Players by Revenue (2017-2022)
        3.1.2 Global Covid-19 Diagnostic Revenue Market Share by Players (2017-2022)
    3.2 Global Covid-19 Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Covid-19 Diagnostic Revenue
    3.4 Global Covid-19 Diagnostic Market Concentration Ratio
        3.4.1 Global Covid-19 Diagnostic Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Covid-19 Diagnostic Revenue in 2021
    3.5 Covid-19 Diagnostic Key Players Head office and Area Served
    3.6 Key Players Covid-19 Diagnostic Product Solution and Service
    3.7 Date of Enter into Covid-19 Diagnostic Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Covid-19 Diagnostic Breakdown Data by Type
    4.1 Global Covid-19 Diagnostic Historic Market Size by Type (2017-2022)
    4.2 Global Covid-19 Diagnostic Forecasted Market Size by Type (2023-2028)
5 Covid-19 Diagnostic Breakdown Data by Application
    5.1 Global Covid-19 Diagnostic Historic Market Size by Application (2017-2022)
    5.2 Global Covid-19 Diagnostic Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Covid-19 Diagnostic Market Size (2017-2028)
    6.2 North America Covid-19 Diagnostic Market Size by Country (2017-2022)
    6.3 North America Covid-19 Diagnostic Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Covid-19 Diagnostic Market Size (2017-2028)
    7.2 Europe Covid-19 Diagnostic Market Size by Country (2017-2022)
    7.3 Europe Covid-19 Diagnostic Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Covid-19 Diagnostic Market Size (2017-2028)
    8.2 Asia-Pacific Covid-19 Diagnostic Market Size by Country (2017-2022)
    8.3 Asia-Pacific Covid-19 Diagnostic Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Covid-19 Diagnostic Market Size (2017-2028)
    9.2 Latin America Covid-19 Diagnostic Market Size by Country (2017-2022)
    9.3 Latin America Covid-19 Diagnostic Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Covid-19 Diagnostic Market Size (2017-2028)
    10.2 Middle East & Africa Covid-19 Diagnostic Market Size by Country (2017-2022)
    10.3 Middle East & Africa Covid-19 Diagnostic Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Abbott Diagnostics
        11.1.1 Abbott Diagnostics Company Detail
        11.1.2 Abbott Diagnostics Business Overview
        11.1.3 Abbott Diagnostics Covid-19 Diagnostic Introduction
        11.1.4 Abbott Diagnostics Revenue in Covid-19 Diagnostic Business (2017-2022)
        11.1.5 Abbott Diagnostics Recent Development
    11.2 Accelerate Diagnostics
        11.2.1 Accelerate Diagnostics Company Detail
        11.2.2 Accelerate Diagnostics Business Overview
        11.2.3 Accelerate Diagnostics Covid-19 Diagnostic Introduction
        11.2.4 Accelerate Diagnostics Revenue in Covid-19 Diagnostic Business (2017-2022)
        11.2.5 Accelerate Diagnostics Recent Development
    11.3 Ador Diagnostics
        11.3.1 Ador Diagnostics Company Detail
        11.3.2 Ador Diagnostics Business Overview
        11.3.3 Ador Diagnostics Covid-19 Diagnostic Introduction
        11.3.4 Ador Diagnostics Revenue in Covid-19 Diagnostic Business (2017-2022)
        11.3.5 Ador Diagnostics Recent Development
    11.4 Akkoni Biosystems
        11.4.1 Akkoni Biosystems Company Detail
        11.4.2 Akkoni Biosystems Business Overview
        11.4.3 Akkoni Biosystems Covid-19 Diagnostic Introduction
        11.4.4 Akkoni Biosystems Revenue in Covid-19 Diagnostic Business (2017-2022)
        11.4.5 Akkoni Biosystems Recent Development
    11.5 Alveo Technologies
        11.5.1 Alveo Technologies Company Detail
        11.5.2 Alveo Technologies Business Overview
        11.5.3 Alveo Technologies Covid-19 Diagnostic Introduction
        11.5.4 Alveo Technologies Revenue in Covid-19 Diagnostic Business (2017-2022)
        11.5.5 Alveo Technologies Recent Development
    11.6 Applied BioCode
        11.6.1 Applied BioCode Company Detail
        11.6.2 Applied BioCode Business Overview
        11.6.3 Applied BioCode Covid-19 Diagnostic Introduction
        11.6.4 Applied BioCode Revenue in Covid-19 Diagnostic Business (2017-2022)
        11.6.5 Applied BioCode Recent Development
    11.7 Aus Diagnostics
        11.7.1 Aus Diagnostics Company Detail
        11.7.2 Aus Diagnostics Business Overview
        11.7.3 Aus Diagnostics Covid-19 Diagnostic Introduction
        11.7.4 Aus Diagnostics Revenue in Covid-19 Diagnostic Business (2017-2022)
        11.7.5 Aus Diagnostics Recent Development
    11.8 BD Diagnostics
        11.8.1 BD Diagnostics Company Detail
        11.8.2 BD Diagnostics Business Overview
        11.8.3 BD Diagnostics Covid-19 Diagnostic Introduction
        11.8.4 BD Diagnostics Revenue in Covid-19 Diagnostic Business (2017-2022)
        11.8.5 BD Diagnostics Recent Development
    11.9 Biocartis
        11.9.1 Biocartis Company Detail
        11.9.2 Biocartis Business Overview
        11.9.3 Biocartis Covid-19 Diagnostic Introduction
        11.9.4 Biocartis Revenue in Covid-19 Diagnostic Business (2017-2022)
        11.9.5 Biocartis Recent Development
    11.10 BioFire Diagnostics
        11.10.1 BioFire Diagnostics Company Detail
        11.10.2 BioFire Diagnostics Business Overview
        11.10.3 BioFire Diagnostics Covid-19 Diagnostic Introduction
        11.10.4 BioFire Diagnostics Revenue in Covid-19 Diagnostic Business (2017-2022)
        11.10.5 BioFire Diagnostics Recent Development
    11.11 bioM?(C)rieux
        11.11.1 bioM?(C)rieux Company Detail
        11.11.2 bioM?(C)rieux Business Overview
        11.11.3 bioM?(C)rieux Covid-19 Diagnostic Introduction
        11.11.4 bioM?(C)rieux Revenue in Covid-19 Diagnostic Business (2017-2022)
        11.11.5 bioM?(C)rieux Recent Development
    11.12 Bio-Rad Laboratories
        11.12.1 Bio-Rad Laboratories Company Detail
        11.12.2 Bio-Rad Laboratories Business Overview
        11.12.3 Bio-Rad Laboratories Covid-19 Diagnostic Introduction
        11.12.4 Bio-Rad Laboratories Revenue in Covid-19 Diagnostic Business (2017-2022)
        11.12.5 Bio-Rad Laboratories Recent Development
    11.13 Bosch Healthcare Solutions GmbH
        11.13.1 Bosch Healthcare Solutions GmbH Company Detail
        11.13.2 Bosch Healthcare Solutions GmbH Business Overview
        11.13.3 Bosch Healthcare Solutions GmbH Covid-19 Diagnostic Introduction
        11.13.4 Bosch Healthcare Solutions GmbH Revenue in Covid-19 Diagnostic Business (2017-2022)
        11.13.5 Bosch Healthcare Solutions GmbH Recent Development
    11.14 Cepheid
        11.14.1 Cepheid Company Detail
        11.14.2 Cepheid Business Overview
        11.14.3 Cepheid Covid-19 Diagnostic Introduction
        11.14.4 Cepheid Revenue in Covid-19 Diagnostic Business (2017-2022)
        11.14.5 Cepheid Recent Development
    11.15 Co-Diagnostics
        11.15.1 Co-Diagnostics Company Detail
        11.15.2 Co-Diagnostics Business Overview
        11.15.3 Co-Diagnostics Covid-19 Diagnostic Introduction
        11.15.4 Co-Diagnostics Revenue in Covid-19 Diagnostic Business (2017-2022)
        11.15.5 Co-Diagnostics Recent Development
    11.16 Cue Health
        11.16.1 Cue Health Company Detail
        11.16.2 Cue Health Business Overview
        11.16.3 Cue Health Covid-19 Diagnostic Introduction
        11.16.4 Cue Health Revenue in Covid-19 Diagnostic Business (2017-2022)
        11.16.5 Cue Health Recent Development
    11.17 Curetis
        11.17.1 Curetis Company Detail
        11.17.2 Curetis Business Overview
        11.17.3 Curetis Covid-19 Diagnostic Introduction
        11.17.4 Curetis Revenue in Covid-19 Diagnostic Business (2017-2022)
        11.17.5 Curetis Recent Development
    11.18 Diagenode Diagnostics
        11.18.1 Diagenode Diagnostics Company Detail
        11.18.2 Diagenode Diagnostics Business Overview
        11.18.3 Diagenode Diagnostics Covid-19 Diagnostic Introduction
        11.18.4 Diagenode Diagnostics Revenue in Covid-19 Diagnostic Business (2017-2022)
        11.18.5 Diagenode Diagnostics Recent Development
    11.19 Diascopic
        11.19.1 Diascopic Company Detail
        11.19.2 Diascopic Business Overview
        11.19.3 Diascopic Covid-19 Diagnostic Introduction
        11.19.4 Diascopic Revenue in Covid-19 Diagnostic Business (2017-2022)
        11.19.5 Diascopic Recent Development
    11.20 Diasorin
        11.20.1 Diasorin Company Detail
        11.20.2 Diasorin Business Overview
        11.20.3 Diasorin Covid-19 Diagnostic Introduction
        11.20.4 Diasorin Revenue in Covid-19 Diagnostic Business (2017-2022)
        11.20.5 Diasorin Recent Development
    11.21 Expedeon
        11.21.1 Expedeon Company Detail
        11.21.2 Expedeon Business Overview
        11.21.3 Expedeon Covid-19 Diagnostic Introduction
        11.21.4 Expedeon Revenue in Covid-19 Diagnostic Business (2017-2022)
        11.21.5 Expedeon Recent Development
    11.22 Fusion Genomics.
        11.22.1 Fusion Genomics. Company Detail
        11.22.2 Fusion Genomics. Business Overview
        11.22.3 Fusion Genomics. Covid-19 Diagnostic Introduction
        11.22.4 Fusion Genomics. Revenue in Covid-19 Diagnostic Business (2017-2022)
        11.22.5 Fusion Genomics. Recent Development
    11.23 GenePOC Diagnostics
        11.23.1 GenePOC Diagnostics Company Detail
        11.23.2 GenePOC Diagnostics Business Overview
        11.23.3 GenePOC Diagnostics Covid-19 Diagnostic Introduction
        11.23.4 GenePOC Diagnostics Revenue in Covid-19 Diagnostic Business (2017-2022)
        11.23.5 GenePOC Diagnostics Recent Development
    11.24 GenMark Dx
        11.24.1 GenMark Dx Company Detail
        11.24.2 GenMark Dx Business Overview
        11.24.3 GenMark Dx Covid-19 Diagnostic Introduction
        11.24.4 GenMark Dx Revenue in Covid-19 Diagnostic Business (2017-2022)
        11.24.5 GenMark Dx Recent Development
    11.25 Hologic
        11.25.1 Hologic Company Detail
        11.25.2 Hologic Business Overview
        11.25.3 Hologic Covid-19 Diagnostic Introduction
        11.25.4 Hologic Revenue in Covid-19 Diagnostic Business (2017-2022)
        11.25.5 Hologic Recent Development
    11.26 Immunexpress
        11.26.1 Immunexpress Company Detail
        11.26.2 Immunexpress Business Overview
        11.26.3 Immunexpress Covid-19 Diagnostic Introduction
        11.26.4 Immunexpress Revenue in Covid-19 Diagnostic Business (2017-2022)
        11.26.5 Immunexpress Recent Development
    11.27 Inflammatix
        11.27.1 Inflammatix Company Detail
        11.27.2 Inflammatix Business Overview
        11.27.3 Inflammatix Covid-19 Diagnostic Introduction
        11.27.4 Inflammatix Revenue in Covid-19 Diagnostic Business (2017-2022)
        11.27.5 Inflammatix Recent Development
    11.28 Invetech
        11.28.1 Invetech Company Detail
        11.28.2 Invetech Business Overview
        11.28.3 Invetech Covid-19 Diagnostic Introduction
        11.28.4 Invetech Revenue in Covid-19 Diagnostic Business (2017-2022)
        11.28.5 Invetech Recent Development
    11.29 Janssen Diagnostics
        11.29.1 Janssen Diagnostics Company Detail
        11.29.2 Janssen Diagnostics Business Overview
        11.29.3 Janssen Diagnostics Covid-19 Diagnostic Introduction
        11.29.4 Janssen Diagnostics Revenue in Covid-19 Diagnostic Business (2017-2022)
        11.29.5 Janssen Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables Table 1. Global Covid-19 Diagnostic Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Immunoassay Table 3. Key Players of Genomic and WGS Role Table 4. Key Players of rRT-PCR Table 5. Global Covid-19 Diagnostic Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Covid-19 Diagnostic Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global Covid-19 Diagnostic Market Size by Region (2017-2022) & (US$ Million) Table 8. Global Covid-19 Diagnostic Market Share by Region (2017-2022) Table 9. Global Covid-19 Diagnostic Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 10. Global Covid-19 Diagnostic Market Share by Region (2023-2028) Table 11. Covid-19 Diagnostic Market Trends Table 12. Covid-19 Diagnostic Market Drivers Table 13. Covid-19 Diagnostic Market Challenges Table 14. Covid-19 Diagnostic Market Restraints Table 15. Global Covid-19 Diagnostic Revenue by Players (2017-2022) & (US$ Million) Table 16. Global Covid-19 Diagnostic Market Share by Players (2017-2022) Table 17. Global Top Covid-19 Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Covid-19 Diagnostic as of 2021) Table 18. Ranking of Global Top Covid-19 Diagnostic Companies by Revenue (US$ Million) in 2021 Table 19. Global 5 Largest Players Market Share by Covid-19 Diagnostic Revenue (CR5 and HHI) & (2017-2022) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Covid-19 Diagnostic Product Solution and Service Table 22. Date of Enter into Covid-19 Diagnostic Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Covid-19 Diagnostic Market Size by Type (2017-2022) & (US$ Million) Table 25. Global Covid-19 Diagnostic Revenue Market Share by Type (2017-2022) Table 26. Global Covid-19 Diagnostic Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 27. Global Covid-19 Diagnostic Revenue Market Share by Type (2023-2028) Table 28. Global Covid-19 Diagnostic Market Size by Application (2017-2022) & (US$ Million) Table 29. Global Covid-19 Diagnostic Revenue Market Share by Application (2017-2022) Table 30. Global Covid-19 Diagnostic Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 31. Global Covid-19 Diagnostic Revenue Market Share by Application (2023-2028) Table 32. North America Covid-19 Diagnostic Market Size by Country (2017-2022) & (US$ Million) Table 33. North America Covid-19 Diagnostic Market Size by Country (2023-2028) & (US$ Million) Table 34. Europe Covid-19 Diagnostic Market Size by Country (2017-2022) & (US$ Million) Table 35. Europe Covid-19 Diagnostic Market Size by Country (2023-2028) & (US$ Million) Table 36. Asia-Pacific Covid-19 Diagnostic Market Size by Region (2017-2022) & (US$ Million) Table 37. Asia-Pacific Covid-19 Diagnostic Market Size by Region (2023-2028) & (US$ Million) Table 38. Latin America Covid-19 Diagnostic Market Size by Country (2017-2022) & (US$ Million) Table 39. Latin America Covid-19 Diagnostic Market Size by Country (2023-2028) & (US$ Million) Table 40. Middle East & Africa Covid-19 Diagnostic Market Size by Country (2017-2022) & (US$ Million) Table 41. Middle East & Africa Covid-19 Diagnostic Market Size by Country (2023-2028) & (US$ Million) Table 42. Abbott Diagnostics Company Detail Table 43. Abbott Diagnostics Business Overview Table 44. Abbott Diagnostics Covid-19 Diagnostic Product Table 45. Abbott Diagnostics Revenue in Covid-19 Diagnostic Business (2017-2022) & (US$ Million) Table 46. Abbott Diagnostics Recent Development Table 47. Accelerate Diagnostics Company Detail Table 48. Accelerate Diagnostics Business Overview Table 49. Accelerate Diagnostics Covid-19 Diagnostic Product Table 50. Accelerate Diagnostics Revenue in Covid-19 Diagnostic Business (2017-2022) & (US$ Million) Table 51. Accelerate Diagnostics Recent Development Table 52. Ador Diagnostics Company Detail Table 53. Ador Diagnostics Business Overview Table 54. Ador Diagnostics Covid-19 Diagnostic Product Table 55. Ador Diagnostics Revenue in Covid-19 Diagnostic Business (2017-2022) & (US$ Million) Table 56. Ador Diagnostics Recent Development Table 57. Akkoni Biosystems Company Detail Table 58. Akkoni Biosystems Business Overview Table 59. Akkoni Biosystems Covid-19 Diagnostic Product Table 60. Akkoni Biosystems Revenue in Covid-19 Diagnostic Business (2017-2022) & (US$ Million) Table 61. Akkoni Biosystems Recent Development Table 62. Alveo Technologies Company Detail Table 63. Alveo Technologies Business Overview Table 64. Alveo Technologies Covid-19 Diagnostic Product Table 65. Alveo Technologies Revenue in Covid-19 Diagnostic Business (2017-2022) & (US$ Million) Table 66. Alveo Technologies Recent Development Table 67. Applied BioCode Company Detail Table 68. Applied BioCode Business Overview Table 69. Applied BioCode Covid-19 Diagnostic Product Table 70. Applied BioCode Revenue in Covid-19 Diagnostic Business (2017-2022) & (US$ Million) Table 71. Applied BioCode Recent Development Table 72. Aus Diagnostics Company Detail Table 73. Aus Diagnostics Business Overview Table 74. Aus Diagnostics Covid-19 Diagnostic Product Table 75. Aus Diagnostics Revenue in Covid-19 Diagnostic Business (2017-2022) & (US$ Million) Table 76. Aus Diagnostics Recent Development Table 77. BD Diagnostics Company Detail Table 78. BD Diagnostics Business Overview Table 79. BD Diagnostics Covid-19 Diagnostic Product Table 80. BD Diagnostics Revenue in Covid-19 Diagnostic Business (2017-2022) & (US$ Million) Table 81. BD Diagnostics Recent Development Table 82. Biocartis Company Detail Table 83. Biocartis Business Overview Table 84. Biocartis Covid-19 Diagnostic Product Table 85. Biocartis Revenue in Covid-19 Diagnostic Business (2017-2022) & (US$ Million) Table 86. Biocartis Recent Development Table 87. BioFire Diagnostics Company Detail Table 88. BioFire Diagnostics Business Overview Table 89. BioFire Diagnostics Covid-19 Diagnostic Product Table 90. BioFire Diagnostics Revenue in Covid-19 Diagnostic Business (2017-2022) & (US$ Million) Table 91. BioFire Diagnostics Recent Development Table 92. bioM?(C)rieux Company Detail Table 93. bioM?(C)rieux Business Overview Table 94. bioM?(C)rieux Covid-19 DiagnosticProduct Table 95. bioM?(C)rieux Revenue in Covid-19 Diagnostic Business (2017-2022) & (US$ Million) Table 96. bioM?(C)rieux Recent Development Table 97. Bio-Rad Laboratories Company Detail Table 98. Bio-Rad Laboratories Business Overview Table 99. Bio-Rad Laboratories Covid-19 DiagnosticProduct Table 100. Bio-Rad Laboratories Revenue in Covid-19 Diagnostic Business (2017-2022) & (US$ Million) Table 101. Bio-Rad Laboratories Recent Development Table 102. Bosch Healthcare Solutions GmbH Company Detail Table 103. Bosch Healthcare Solutions GmbH Business Overview Table 104. Bosch Healthcare Solutions GmbH Covid-19 DiagnosticProduct Table 105. Bosch Healthcare Solutions GmbH Revenue in Covid-19 Diagnostic Business (2017-2022) & (US$ Million) Table 106. Bosch Healthcare Solutions GmbH Recent Development Table 107. Cepheid Company Detail Table 108. Cepheid Business Overview Table 109. Cepheid Covid-19 DiagnosticProduct Table 110. Cepheid Revenue in Covid-19 Diagnostic Business (2017-2022) & (US$ Million) Table 111. Cepheid Recent Development Table 112. Co-Diagnostics Company Detail Table 113. Co-Diagnostics Business Overview Table 114. Co-Diagnostics Covid-19 DiagnosticProduct Table 115. Co-Diagnostics Revenue in Covid-19 Diagnostic Business (2017-2022) & (US$ Million) Table 116. Co-Diagnostics Recent Development Table 117. Cue Health Company Detail Table 118. Cue Health Business Overview Table 119. Cue Health Covid-19 DiagnosticProduct Table 120. Cue Health Revenue in Covid-19 Diagnostic Business (2017-2022) & (US$ Million) Table 121. Cue Health Recent Development Table 122. Curetis Company Detail Table 123. Curetis Business Overview Table 124. Curetis Covid-19 DiagnosticProduct Table 125. Curetis Revenue in Covid-19 Diagnostic Business (2017-2022) & (US$ Million) Table 126. Curetis Recent Development Table 127. Diagenode Diagnostics Company Detail Table 128. Diagenode Diagnostics Business Overview Table 129. Diagenode Diagnostics Covid-19 DiagnosticProduct Table 130. Diagenode Diagnostics Revenue in Covid-19 Diagnostic Business (2017-2022) & (US$ Million) Table 131. Diagenode Diagnostics Recent Development Table 132. Diascopic Company Detail Table 133. Diascopic Business Overview Table 134. Diascopic Covid-19 DiagnosticProduct Table 135. Diascopic Revenue in Covid-19 Diagnostic Business (2017-2022) & (US$ Million) Table 136. Diascopic Recent Development Table 137. Diasorin Company Detail Table 138. Diasorin Business Overview Table 139. Diasorin Covid-19 DiagnosticProduct Table 140. Diasorin Revenue in Covid-19 Diagnostic Business (2017-2022) & (US$ Million) Table 141. Diasorin Recent Development Table 142. Expedeon Company Detail Table 143. Expedeon Business Overview Table 144. Expedeon Covid-19 DiagnosticProduct Table 145. Expedeon Revenue in Covid-19 Diagnostic Business (2017-2022) & (US$ Million) Table 146. Expedeon Recent Development Table 147. Fusion Genomics. Company Detail Table 148. Fusion Genomics. Business Overview Table 149. Fusion Genomics. Covid-19 DiagnosticProduct Table 150. Fusion Genomics. Revenue in Covid-19 Diagnostic Business (2017-2022) & (US$ Million) Table 151. Fusion Genomics. Recent Development Table 152. GenePOC Diagnostics Company Detail Table 153. GenePOC Diagnostics Business Overview Table 154. GenePOC Diagnostics Covid-19 DiagnosticProduct Table 155. GenePOC Diagnostics Revenue in Covid-19 Diagnostic Business (2017-2022) & (US$ Million) Table 156. GenePOC Diagnostics Recent Development Table 157. GenMark Dx Company Detail Table 158. GenMark Dx Business Overview Table 159. GenMark Dx Covid-19 DiagnosticProduct Table 160. GenMark Dx Revenue in Covid-19 Diagnostic Business (2017-2022) & (US$ Million) Table 161. GenMark Dx Recent Development Table 162. Hologic Company Detail Table 163. Hologic Business Overview Table 164. Hologic Covid-19 DiagnosticProduct Table 165. Hologic Revenue in Covid-19 Diagnostic Business (2017-2022) & (US$ Million) Table 166. Hologic Recent Development Table 167. Immunexpress Company Detail Table 168. Immunexpress Business Overview Table 169. Immunexpress Covid-19 DiagnosticProduct Table 170. Immunexpress Revenue in Covid-19 Diagnostic Business (2017-2022) & (US$ Million) Table 171. Immunexpress Recent Development Table 172. Inflammatix Company Detail Table 173. Inflammatix Business Overview Table 174. Inflammatix Covid-19 DiagnosticProduct Table 175. Inflammatix Revenue in Covid-19 Diagnostic Business (2017-2022) & (US$ Million) Table 176. Inflammatix Recent Development Table 177. Invetech Company Detail Table 178. Invetech Business Overview Table 179. Invetech Covid-19 DiagnosticProduct Table 180. Invetech Revenue in Covid-19 Diagnostic Business (2017-2022) & (US$ Million) Table 181. Invetech Recent Development Table 182. Janssen Diagnostics Company Detail Table 183. Janssen Diagnostics Business Overview Table 184. Janssen Diagnostics Covid-19 DiagnosticProduct Table 185. Janssen Diagnostics Revenue in Covid-19 Diagnostic Business (2017-2022) & (US$ Million) Table 186. Janssen Diagnostics Recent Development Table 187. Research Programs/Design for This Report Table 188. Key Data Information from Secondary Sources Table 189. Key Data Information from Primary Sources List of Figures Figure 1. Global Covid-19 Diagnostic Market Share by Type: 2021 VS 2028 Figure 2. Immunoassay Features Figure 3. Genomic and WGS Role Features Figure 4. rRT-PCR Features Figure 5. Global Covid-19 Diagnostic Market Share by Application in 2021 & 2028 Figure 6. Hospital Case Studies Figure 7. Laboratory Case Studies Figure 8. Covid-19 Diagnostic Report Years Considered Figure 9. Global Covid-19 Diagnostic Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 10. Global Covid-19 Diagnostic Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 11. Global Covid-19 Diagnostic Market Share by Region: 2021 VS 2028 Figure 12. Global Covid-19 Diagnostic Market Share by Players in 2021 Figure 13. Global Top Covid-19 Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Covid-19 Diagnostic as of 2021) Figure 14. The Top 10 and 5 Players Market Share by Covid-19 Diagnostic Revenue in 2021 Figure 15. North America Covid-19 Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million) Figure 16. North America Covid-19 Diagnostic Market Share by Country (2017-2028) Figure 17. United States Covid-19 Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million) Figure 18. Canada Covid-19 Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. Europe Covid-19 Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Europe Covid-19 Diagnostic Market Share by Country (2017-2028) Figure 21. Germany Covid-19 Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. France Covid-19 Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. U.K. Covid-19 Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. Italy Covid-19 Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. Russia Covid-19 Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Nordic Countries Covid-19 Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Asia-Pacific Covid-19 Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Asia-Pacific Covid-19 Diagnostic Market Share by Region (2017-2028) Figure 29. China Covid-19 Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Japan Covid-19 Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. South Korea Covid-19 Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Southeast Asia Covid-19 Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. India Covid-19 Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Australia Covid-19 Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Latin America Covid-19 Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Latin America Covid-19 Diagnostic Market Share by Country (2017-2028) Figure 37. Mexico Covid-19 Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Brazil Covid-19 Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Middle East & Africa Covid-19 Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Middle East & Africa Covid-19 Diagnostic Market Share by Country (2017-2028) Figure 41. Turkey Covid-19 Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Saudi Arabia Covid-19 Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Abbott Diagnostics Revenue Growth Rate in Covid-19 Diagnostic Business (2017-2022) Figure 44. Accelerate Diagnostics Revenue Growth Rate in Covid-19 Diagnostic Business (2017-2022) Figure 45. Ador Diagnostics Revenue Growth Rate in Covid-19 Diagnostic Business (2017-2022) Figure 46. Akkoni Biosystems Revenue Growth Rate in Covid-19 Diagnostic Business (2017-2022) Figure 47. Alveo Technologies Revenue Growth Rate in Covid-19 Diagnostic Business (2017-2022) Figure 48. Applied BioCode Revenue Growth Rate in Covid-19 Diagnostic Business (2017-2022) Figure 49. Aus Diagnostics Revenue Growth Rate in Covid-19 Diagnostic Business (2017-2022) Figure 50. BD Diagnostics Revenue Growth Rate in Covid-19 Diagnostic Business (2017-2022) Figure 51. Biocartis Revenue Growth Rate in Covid-19 Diagnostic Business (2017-2022) Figure 52. BioFire Diagnostics Revenue Growth Rate in Covid-19 Diagnostic Business (2017-2022) Figure 53. bioM?(C)rieux Revenue Growth Rate in Covid-19 Diagnostic Business (2017-2022) Figure 54. Bio-Rad Laboratories Revenue Growth Rate in Covid-19 Diagnostic Business (2017-2022) Figure 55. Bosch Healthcare Solutions GmbH Revenue Growth Rate in Covid-19 Diagnostic Business (2017-2022) Figure 56. Cepheid Revenue Growth Rate in Covid-19 Diagnostic Business (2017-2022) Figure 57. Co-Diagnostics Revenue Growth Rate in Covid-19 Diagnostic Business (2017-2022) Figure 58. Cue Health Revenue Growth Rate in Covid-19 Diagnostic Business (2017-2022) Figure 59. Curetis Revenue Growth Rate in Covid-19 Diagnostic Business (2017-2022) Figure 60. Diagenode Diagnostics Revenue Growth Rate in Covid-19 Diagnostic Business (2017-2022) Figure 61. Diascopic Revenue Growth Rate in Covid-19 Diagnostic Business (2017-2022) Figure 62. Diasorin Revenue Growth Rate in Covid-19 Diagnostic Business (2017-2022) Figure 63. Expedeon Revenue Growth Rate in Covid-19 Diagnostic Business (2017-2022) Figure 64. Fusion Genomics. Revenue Growth Rate in Covid-19 Diagnostic Business (2017-2022) Figure 65. GenePOC Diagnostics Revenue Growth Rate in Covid-19 Diagnostic Business (2017-2022) Figure 66. GenMark Dx Revenue Growth Rate in Covid-19 Diagnostic Business (2017-2022) Figure 67. Hologic Revenue Growth Rate in Covid-19 Diagnostic Business (2017-2022) Figure 68. Immunexpress Revenue Growth Rate in Covid-19 Diagnostic Business (2017-2022) Figure 69. Inflammatix Revenue Growth Rate in Covid-19 Diagnostic Business (2017-2022) Figure 70. Invetech Revenue Growth Rate in Covid-19 Diagnostic Business (2017-2022) Figure 71. Janssen Diagnostics Revenue Growth Rate in Covid-19 Diagnostic Business (2017-2022) Figure 72. Bottom-up and Top-down Approaches for This Report Figure 73. Data Triangulation Figure 74. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us